Health-related quality of life following valoctocogene roxaparvovec gene therapy for severe hemophilia A in the phase 3 trial GENEr8-1
| dc.article.end-page | 3462 | en |
| dc.article.start-page | 3450 | en |
| dc.citation.doi | 10.1016/J.JTHA.2023.08.032 | en |
| dc.contributor.author | Brian O' Mahony | en |
| dc.contributor.author | Amy L Dunn | en |
| dc.contributor.author | Andrew D Leavitt | en |
| dc.contributor.author | F Peyvandi | en |
| dc.contributor.author | Johnny Mahlangu | en |
| dc.contributor.author | E et al | en |
| dc.date.accessioned | 2024-07-23T05:59:44Z | |
| dc.date.available | 2024-07-23T05:59:44Z | |
| dc.faculty | FACULTY OF HEALTH SCIENCES | en |
| dc.identifier.citation | WOS | en |
| dc.identifier.issn | 1538-7933 | en |
| dc.identifier.uri | https://hdl.handle.net/10539/39497 | |
| dc.journal.title | Health-related quality of life following valoctocogene roxaparvovec gene therapy for severe hemophilia A in the phase 3 trial GENEr8-1 | en |
| dc.journal.volume | 21 | en |
| dc.publisher | WILEY-BLACKWELL | en |
| dc.title | Health-related quality of life following valoctocogene roxaparvovec gene therapy for severe hemophilia A in the phase 3 trial GENEr8-1 | en |
| dc.type | Journal Article | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Journal Article.pdf
- Size:
- 875 KB
- Format:
- Adobe Portable Document Format
- Description:
- Bitstream uploaded by REST Client